Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York, Second in the Nation, and First for Urology Care by U.S. News & World Report

Middle East, 11 August 2025: Memorial Sloan Kettering Cancer Center (MSK), a global leader in cancer care and research, has been recognized as the best cancer center in the Northeast United States and New York, the number two hospital for cancer care in the United States, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing. MSK has ranked as one of the top two cancer hospitals in the U.S. and the best cancer center in New York since these rankings were established more than 35 years ago., underscoring its longstanding commitment to excellence and innovation in cancer treatment.

“This recognition reminds us of MSK’s unique role in the history and future of cancer care and the obligation we have to patients. We are committed to providing world-class cancer care and pursuing breakthrough research to advance our mission of ending cancer for life. MSK is the most advanced and innovative force against cancer in the world. We will continue to be dedicated to helping individuals with cancer live healthier, more fulfilling lives during and after treatment, ensuring they not only survive but thrive,” said Selwyn M. Vickers, MD, FACS, President & CEO of MSK.

In addition to its leadership in cancer and urology, MSK received national recognition in the United States for high-performing programs in colon cancer surgery, gynecologic cancer surgery, lung cancer surgery, prostate cancer surgery, and treatment of blood cancers such as leukemia, lymphoma, and myeloma.

In the Middle East, the growing incidence of prostate cancer has underscored the importance of advancing access to world-class oncology and urology expertise. According to the UAE Ministry of Health and Prevention’s National Cancer Registry, prostate cancer is now the second most common cancer among men in the country, accounting for nearly 10% of all invasive male cancer cases diagnosed in 2021. While many cancer types are increasingly being treated within the region, patients and government healthcare sponsors continue to seek specialized overseas treatment for complex cases. MSK’s globally recognized leadership in these areas positions the institution as a collaborative referral center for patients across the Middle East, offering multidisciplinary, personalized care for cases that require the highest level of expertise.

MSK has been increasingly working with healthcare providers across the world, sharing expertise in complex cancer cases and innovations in precision medicine, immunotherapy, and early detection strategies. The driving force for these efforts is to increase accessibility to some of the most advance offerings for the diagnosis and treatment of cancer.

This year’s recognition as one of the top cancer hospitals in the country coincides with groundbreaking achievements by MSK in research, clinical care, and education. Highlights include a pioneering MSK-developed immunotherapy-only treatment that enhances patients’ quality of life; FDA approval of 11 new therapies from MSK-led clinical trials; the ANCC Magnet® designation for nursing excellence for the third time; expanded efforts to improve community access to cancer screening; advancements in precision medicine through genomic-based diagnostics and therapies; and innovative strides in cancer vaccine development, positioning MSK at the forefront of oncology’s future.

This is the third consecutive year MSK has been ranked as the number one hospital for urology care in the United States. The MSK’s urology service team is comprised of world-class specialists in surgery, medical oncology, chemotherapy, radiation oncology, radiology, pathology, and nursing, who collaborate to deliver the best treatment for each patient, focusing on innovation, care, and preserving quality of life.

The U.S. News & World Report rankings were developed for patients with life-threatening or rare conditions who need a hospital that excels at treating complex, high-risk cases. Rankings are based largely on publicly available data sources, including survival rates for serious cases, patient experience and other performance measures that can be assessed using hard data, such as whether patients are able to return home after being discharged. A portion of the scores is determined by expert opinions, which draw from three years of surveys of physician specialists from across the United States, who were asked where they would refer their sickest patients.

Patients from over 100 countries have traveled to MSK in New York to receive cancer care from world-renowned oncologists, surgeons, and other medical experts. The multilingual and culturally attuned team at MSK’s Bobst International Center continues to help patients from the Middle East with travel and treatment logistics.

About Memorial Sloan Kettering Cancer Center:

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research conducted at our Sloan Kettering Institute, scientists across MSK collaborate on innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it.

We are dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. MSK is one of the world’s most respected comprehensive centers devoted exclusively to cancer. We have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 35 years.

For more information, please visit mskcc.org/international